Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06243718 · ClinicalTrials.gov registry record
Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.
A clinical trial of Breath Shortness and Diaphragmatic Paralysis, sponsored by Advanced Reconstructive Surgery Alliance.
- Recruiting
- Registry status
- 45
- Enrollment target
- 2
- Study locations
NCT06243718 is a study of Breath Shortness and Diaphragmatic Paralysis that is actively recruiting participants, run by Advanced Reconstructive Surgery Alliance. The registered enrollment target is 45 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT06243718, a study of Breath Shortness and Diaphragmatic Paralysis, is actively recruiting participants, sponsored by Advanced Reconstructive Surgery Alliance.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study utilizes a grounded theory methodology to explore patient experiences of phrenic nerve reconstructive surgery as a treatment for diaphragmatic paralysis.
Conditions Studied
Study Locations (2)
New Jersey
- Advanced Reconstructive Surgery Alliance - Red Bank
- Institute for Advanced Reconstruction - Shrewsbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2026-10-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06243718
The ClinicalTrials.gov registry entry for NCT06243718 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advanced Reconstructive Surgery Alliance, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breath Shortness appearing as the primary indexed condition, and to 0 interventions.
NCT06243718 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06243718 about?
NCT06243718 is a clinical study titled "Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.". This study utilizes a grounded theory methodology to explore patient experiences of phrenic nerve reconstructive surgery as a treatment for diaphragmatic paralysis.
What is the current status of trial NCT06243718?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2023-10-10. Estimated completion is 2026-10-10.
What conditions does trial NCT06243718 study?
This clinical trial studies the following conditions: Breath Shortness, Diaphragmatic Paralysis, Pain, Chest.
Who is sponsoring clinical trial NCT06243718?
This trial is sponsored by Advanced Reconstructive Surgery Alliance, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06243718 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breath Shortness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.